Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Forte Biosciences Inc (NQ: FBRX )

0.5860 -0.0040 (-0.68%)
Streaming Delayed Price Updated: 1:41 PM EDT, May 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 25,007
Open 0.5500
Bid (Size) 0.5700 (30)
Ask (Size) 0.6300 (10)
Prev. Close 0.5900
Today's Range 0.5500 - 0.6200
52wk Range 0.3800 - 1.060
Shares Outstanding 21,051,195
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
From Forte Biosciences, Inc.
Via Business Wire
FBRX Stock Earnings: Forte Biosciences Reported Results for Q1 2024
Forte Biosciences just reported results for the first quarter of 2024. 
Via InvestorPlace

Performance

YTD
-29.40%
-29.40%
1 Month
-18.61%
-18.61%
3 Month
-16.29%
-16.29%
6 Month
+35.49%
+35.49%
1 Year
-43.11%
-43.11%

More News

Read More
Forte Biosciences, Inc. Announces First Quarter 2024 Results and Provides Business Update
From Forte Biosciences, Inc.
Via Business Wire
FBRX Stock Earnings: Forte Biosciences Reported Results for Q4 2023
Via InvestorPlace
Forte Biosciences, Inc. Announces 2023 Results and Provides Business Update
From Forte Biosciences, Inc.
Via Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Research Frontiers And 3 Other Stocks Under $1 Insiders Are Buying
Via Benzinga
Topics Stocks
Exposures US Equities
RiskOn International And 3 Other Stocks Under $2 Insiders Are Buying
Via Benzinga
Topics Stocks
Exposures US Equities
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules
From Forte Biosciences, Inc.
Via Business Wire
Insiders Buying Vintage Wine Estates And 3 Other Stocks Under $1
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Forte Biosciences, Inc. Announces Third Quarter 2023 Results and Provides Business Update
From Forte Biosciences, Inc.
Via Business Wire
ISS and Glass Lewis Recommend Forte Biosciences Stockholders Vote FOR Boardroom Change at the Company’s Upcoming Annual Meeting
From On behalf of Concerned Stockholders of Forte
Via Business Wire
Concerned Stockholders of Forte Biosciences and Its Independent Director Candidates Share Key Facts that Reinforce the Need for Urgent Change in the Company’s Boardroom
From On behalf of Concerned Stockholders of Forte
Via Business Wire
Concerned Stockholders of Forte Biosciences File Definitive Proxy Statement and Send Letter to Stockholders
From On behalf of Concerned Stockholders of Forte
Via Business Wire
Forte Biosciences, Inc. Announces Second Quarter 2023 Results and Provides Business Update
From Forte Biosciences, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Forte Biosciences, Inc. Announces $25 Million Financing and R&D Update for FB-102
From Forte Biosciences, Inc.
Via Business Wire
Earnings Scheduled For May 26, 2023
Via Benzinga
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules
From Forte Biosciences, Inc.
Via Business Wire
Forte Biosciences, Inc. Announces First Quarter 2023 Results and Provides Business Update
From Forte Biosciences, Inc.
Via Business Wire
Forte Biosciences, Inc. Announces Full Year 2022 Results and Provides Business Update
From Forte Biosciences, Inc.
Via Business Wire
Mr. David Gryska Appointed to Forte Biosciences Board of Directors
From Forte Biosciences, Inc.
Via Business Wire
Forte Biosciences, Inc. Announces Third Quarter 2022 Results and Provides Business Update
From Forte Biosciences, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.